MEDVF Dividend: Medivolve Inc Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

MEDVF Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Revenue	0	0	1	86	10	0
Revenue Growth (YoY)	-100%	-100%	-99%	760%	--	--
Cost of Revenue	0	0	0	50	5	--
Gross Profit	0	0	0	36	4	--
Selling, General & Admin	4	3	13	21	9	2
Research & Development	--	--	--	--	0	0
Operating Expenses	4	3	13	24	13	2
Other Non Operating Income (Expenses)	--	--	--	0	--	--
Pretax Income	-4	-3	-14	0	-37	-2
Income Tax Expense	--	--	-4	6	--	--
Net Income	-17	-16	-18	-6	-37	-2
Net Income Growth	-11%	-11%	200%	-84%	1,750%	--
Shares Outstanding (Diluted)	27.01	27.01	27.01	19.32	100.09	34.19
Shares Change (YoY)	0%	0%	40%	-81%	193%	0%
EPS (Diluted)	-0.65	-0.61	-0.67	-0.34	-0.37	-0.07
EPS Growth	-11%	-9%	96%	-9%	375%	282%
Free Cash Flow	-1	-2	6	-9	-11	-4
Free Cash Flow Per Share	-0.03	-0.07	0.22	-0.46	-0.1	-0.11
Gross Margin	0%	0%	0%	41.86%	40%	--
Operating Margin	0%	0%	-1,300%	13.95%	-80%	0%
Profit Margin	0%	0%	-1,800%	-6.97%	-370%	0%
Free Cash Flow Margin	0%	0%	600%	-10.46%	-110%	0%
EBITDA	-3	-3	-13	13	-5	--
EBITDA Margin	0%	0%	-1,300%	15.11%	-50%	--
D&A For EBITDA	0	0	0	1	3	--
EBIT	-3	-3	-13	12	-8	-2
EBIT Margin	0%	0%	-1,300%	13.95%	-80%	0%
Effective Tax Rate	--	--	28.57%	0%	--	--